Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Capital Expenditures (2020 - 2025)

Zai Lab (ZLAB) has disclosed Capital Expenditures for 6 consecutive years, with $677000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 73.96% to $677000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Dec 2025, up 43.2% year-over-year, with the annual reading at $8.1 million for FY2025, 43.2% up from the prior year.
  • Capital Expenditures hit $677000.0 in Q4 2025 for Zai Lab, down from $3.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $9.7 million in Q1 2022 to a low of $222000.0 in Q4 2023.
  • Historically, Capital Expenditures has averaged $3.2 million across 5 years, with a median of $2.7 million in 2024.
  • Biggest five-year swings in Capital Expenditures: soared 1424.62% in 2021 and later tumbled 94.97% in 2023.
  • Year by year, Capital Expenditures stood at $6.4 million in 2021, then plummeted by 30.81% to $4.4 million in 2022, then crashed by 94.97% to $222000.0 in 2023, then skyrocketed by 1071.17% to $2.6 million in 2024, then tumbled by 73.96% to $677000.0 in 2025.
  • Business Quant data shows Capital Expenditures for ZLAB at $677000.0 in Q4 2025, $3.0 million in Q3 2025, and $2.9 million in Q2 2025.